Search for: "Fields v. U.S. Securities and Exchange Commission" Results 161 - 180 of 207
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Sep 2011, 11:17 am
Bird 100 So 2d 57 (Fla 1958), Arkansas Commemorative Commission v. [read post]
31 Aug 2011, 10:27 am by Badrinath Srinivasan
In particular, because of the Supreme Court’s recent opinion in AT&T Mobility LLC v. [read post]
29 Aug 2011, 2:00 pm
("Mitsui") is the assignee of U.S. [read post]
23 Aug 2011, 12:46 pm by Stefan Passantino
   Our latest contestants in this Sisyphean legal drama are a united band of like-minded law school professors looking to utilize the Securities and Exchange Commission (SEC) as a vehicle to counter the perceived negative impact of Citizens United. [read post]
8 Aug 2011, 2:00 am by Kara OBrien
Securities and Exchange Commission (No. 10-1305, July 22, 2011), the question is where does proxy access now stand and what can now be expected? [read post]
20 Jul 2011, 5:23 pm
McKessy to a "whistleblower-friendly" crowd since he became Director of the Security and Exchange Commission (SEC) Office of the Whistleblower. [read post]
2 May 2011, 5:29 am by Badrinath Srinivasan
In the third, final part, the author scrutinizes the Commission proposal against the background of the Commission's Impact Assessment before concluding with a short resumé. [read post]
8 Mar 2011, 1:59 pm by Ailyn Cabico
  In doing so, the Securities and Exchange Commission (the “SEC”) sought to strike the proper balance among competing investor interests, with full consideration of appropriate lessons learned from recent spectacular failings concerning adviser reporting to investors. [read post]
22 Dec 2010, 10:22 pm by legalinformatics
Abstract: This study explores how coverage of the U.S. [read post]
3 Oct 2010, 5:00 am by Erik Gerding
Siracusano (09-1156)(Argument not yet scheduled) Background: Respondents filed suit under § 10(b) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5, alleging that petitioners committed securities fraud by failing to disclose "adverse event" reports-i.e., reports by users of a drug that they experienced an adverse event after using the drug. [read post]